CYAD stock forecast for 2023 – 2027

Are you interested in Celyad Oncology SA stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYAD stock price in 2022-2027. Is CYAD a good long term stock? When should I take profit in Celyad Oncology stock? Buy or sell stock? Will CYAD stock price go up? What are analysts’ forecasts for CYAD stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CYAD stock returns are also predicted based on historical data.

According to our research, CYAD stock is a bad long-term investment. CYAD share price has been in a bear cycle for the past year. Celyad Oncology SA stock trend is negative.

Celyad Oncology company info

Industry Biotechnology
Address Axis Business Park, Mont-Saint-Guibert, 1435, Belgium
Website https://www.celyad.com

Forecasting

52 Week High: 3.58938 USD
52 Week Low: 0.00000016236 USD
1 Year Forecast: 0.0000011118 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 56.49M
52 Week Change: -4.342%
52 Week High: 8.44 USD
52 Week Low: 3.28 USD
Beta: 0.175509
50 Day Moving Average: 3.88
90 Day Moving Average: 3.985
200 Day Moving Average: 4.18
Resistance Level: 3.636
Pivot Point: 3.5802
Support Level: 3.4542
Enterprise Value: 56,692,824
Forward P/E: 0
Forward EPS: -4.12
Profit Margin: 0.00%
Shares Outstanding: 22,594,000
EBITDA: -2.27
Held Percent Institutions: 1.25%
PEG Ratio (5Y): 0
Trailing EPS: -1.341

Celyad Oncology stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Celyad Oncology Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%
August 2023 0 0 0%
September 2023 0 0 0%
October 2023 0 0 0%
November 2023 0 0 0%
December 2023 0 0 0%

Celyad Oncology Stock Forecast for 2024

January 2024 0 0 0%
February 2024 0 0 0%
March 2024 0 0 0%

Other companies stock forecasts